TEXT-EXTRACT 2 filename2.txt United States securities and exchange commission logo May 18, 2021 Todd R. Patrick Chief Executive Officer Armata Pharmaceuticals, Inc. 4503 Glencoe Avenue Marina del Rey, California 90292-3552 Re: Armata Pharmaceuticals, Inc. Registration Statement on Form S-3 Filed May 13, 2021 File No. 333-256104 Dear Mr. Patrick: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Margaret Schwartz at 202-551-7153 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Faith Charles, Esq.